Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Otfried Kistner
Observed names:
O KISTNER,
O Kistner,
O. KISTNER,
O. Kistner,
Otfried. Kistner
Institution:
VisMederi (Italy)
Observed institutions:
University of British Columbia,
Queen Mary University of London,
Justus-Liebig-Universität Gießen,
Baxter (Austria),
Nanotherapeutics (United States),
VisMederi (Italy),
Baxter (United States)
show all 7
ORCID:
0000-0003-0828-9550
Observed ORCID:
0000-0003-0828-9550
OpenAlex ID:
A5013621761
The nucleoprotein as a possible major factor in determining host specificity of influenza H3N2 viruses
1985
·
C. Scholtissek
, H. Bürger
, et al.
·
Virology
·
413
Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines
2009
·
P Noel Barrett
, Wolfgang Mundt
, et al.
·
Expert Review of Vaccines
·
315
A Clinical Trial of a Whole-Virus H5N1 Vaccine Derived from Cell Culture
2008
·
Hartmut J. Ehrlich
, Markus Müller
, et al.
·
New England Journal of Medicine
·
286
PDF
Development of a mammalian cell (Vero) derived candidate influenza virus vaccine
1998
·
O KISTNER
, P N Barrett
, et al.
·
Vaccine
·
241
Influenza Viruses and Vaccines: The Role of Vaccine Effectiveness Studies for Evaluation of the Benefits of Influenza Vaccines
2022
·
Claudia Maria Trombetta
, Otfried Kistner
, et al.
·
Vaccines
·
197
PDF
A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses
2005
·
Martin Spruth
, Otfried Kistner
, et al.
·
Vaccine
·
125
PDF
Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses
2007
·
Otfried Kistner
, M. Keith Howard
, et al.
·
Vaccine
·
112
Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial
2011
·
P Noel Barrett
, Gregory Berezuk
, et al.
·
The Lancet
·
111
Influenza D Virus: Serological Evidence in the Italian Population from 2005 to 2017
2019
·
Claudia M. Trombetta
, Serena Marchi
, et al.
·
Viruses
·
92
PDF
West Nile virus and the safety of plasma derivatives: verification of high safety margins, and the validity of predictions based on model virus data
2003
·
Thomas R. Kreil
, Andreas Berting
, et al.
·
Transfusion
·
81
Vero cell technology for rapid development of inactivated whole virus vaccines for emerging viral diseases
2017
·
P. Noel Barrett
, Sara J. Terpening
, et al.
·
Expert Review of Vaccines
·
80
Lack of Innate Interferon Responses during SARS Coronavirus Infection in a Vaccination and Reinfection Ferret Model
2012
·
Mark J. Cameron
, Alyson A. Kelvin
, et al.
·
PLoS ONE
·
74
Differential Phosphorylation of the Nucleoprotein of Influenza A Viruses
1989
·
O. Kistner
, K. Muller
, et al.
·
Journal of General Virology
·
67
Current challenges in implementing cell-derived influenza vaccines: Implications for production and regulation, July 2007, NIBSC, Potters Bar, UK
2009
·
Philip D. Minor
, Othmar G. Engelhardt
, et al.
·
Vaccine
·
64
A Vero Cell–Derived Whole-Virus H5N1 Vaccine Effectively Induces Neuraminidase-Inhibiting Antibodies
2011
·
Richard Fritz
, Nicolas Sabarth
, et al.
·
The Journal of Infectious Diseases
·
59
A Cell Culture (Vero)–Derived H5N1 Whole‐Virus Vaccine Induces Cross‐Reactive Memory Responses
2009
·
Hartmut J. Ehrlich
, Markus Müller
, et al.
·
The Journal of Infectious Diseases
·
50
How to assess the effectiveness of nasal influenza vaccines? Role and measurement of sIgA in mucosal secretions
2019
·
Elena Gianchecchi
, Alessandro Manenti
, et al.
·
Influenza and Other Respiratory Viruses
·
49
PDF
Development of a Vero cell-derived influenza whole virus vaccine.
1999
·
O Kistner
, P N Barrett
, et al.
·
PubMed
·
49
Emerging Influenza Strains in the Last Two Decades: A Threat of a New Pandemic?
2015
·
Claudia Trombetta
, Simona Piccirella
, et al.
·
Vaccines
·
47
PDF
A Whole Virus Pandemic Influenza H1N1 Vaccine Is Highly Immunogenic and Protective in Active Immunization and Passive Protection Mouse Models
2010
·
Otfried Kistner
, Brian A. Crowe
, et al.
·
PLoS ONE
·
47
PDF
In vitro and in vivo anti-retroviral activity of the substance purified from the aqueous extract of Chelidonium majus L.
2006
·
Marijan Gerenčer
, Peter L. Turecek
, et al.
·
Antiviral Research
·
47
Pre-clinical development of cell culture (Vero)-derived H5N1 pandemic vaccines
2008
·
M. Keith Howard
, Otfried Kistner
, et al.
·
Biological Chemistry
·
45
The preclinical testing of a formaldehyde inactivated Ross River virus vaccine designed for use in humans
2007
·
Otfried Kistner
, Noel Barrett
, et al.
·
Vaccine
·
41
Evaluation of an inactivated Ross River virus vaccine in active and passive mouse immunization models and establishment of a correlate of protection
2011
·
Georg W. Holzer
, Sogue Coulibaly
, et al.
·
Vaccine
·
38
Safety and immunogenicity of an inactivated whole virus Vero cell-derived Ross River virus vaccine: A randomized trial
2011
·
Gerald Aichinger
, Hartmut J. Ehrlich
, et al.
·
Vaccine
·
37
Show more works
View as search
Works count:
72
Citation count:
3,540
H-index:
30
I10-index:
57
Year
Topic
Type